Letter: Diagnostic challenges in gastrointestinal calciphylaxis

  • Cleveland Clinic Journal of Medicine
  • September 2026,
  • 93
  • (9)
  • 507;
  • DOI: https://doi.org/10.3949/ccjm.93c.09001

To the Editor: I read with great interest the article by Dr. Gioe and colleagues1 in the June issue in which they described gastrointestinal calciphylaxis in a patient with end-stage renal disease. The article provides valuable insight into an uncommon and diagnostically challenging manifestation of calcific uremic arteriolopathy. Nevertheless, several aspects related to diagnostic interpretation, reliance on surgical pathology, and recognition of gastrointestinal calciphylaxis in routine clinical practice warrant further discussion.

Although the identification of sevelamer crystals provided a plausible explanation for the patient’s colonic ulceration, the presence of crystals also may have acted as a diagnostic confounder. Given the patient’s multiple preexisting risk factors for calciphylaxis, it remains uncertain whether the crystal deposition was the primary pathogenic process or a coincidental finding within the ischemic bowel. Further discussion is needed to explore how characteristic medication-related histologic findings can influence diagnostic reasoning when competing etiologies are present.2,3

Also, the article rightly emphasizes the diagnostic value of the resection specimen. However, it may inadvertently suggest that histopathologic confirmation is the sole prerequisite for diagnosis. In contrast, the calciphylaxis literature often highlights that the condition is frequently suspected clinically, especially when biopsy findings are inconclusive or tissue sampling is limited. Given that the characteristic vascular abnormalities in this case were only identified after colectomy, further discussion of the clinical, biochemical, and radiographic features that could support preoperative suspicion of gastrointestinal calciphylaxis would enhance the report’s applicability to real-world practice, where surgical specimens are often unavailable.4,5

REFERENCES

  1. 1
    Gioe B, Fernandes C, Marginean EC, Subramanian S. Hematochezia in a patient with end-stage renal disease. Cleve Clin J Med 2026; 93(6):333338. doi:10.3949/ccjm.93a.25097
  2. 2
    Yuste C, Mérida E, Hernández E, et al. Gastrointestinal complications induced by sevelamer crystals. Clin Kidney J 2017; 10(4): 539544. doi:10.1093/ckj/sfx013
  3. 3
    Aarabi A, Kumar K. Gastrointestinal calciphylaxis: a rare and devastating complication in end-stage kidney disease. CEN Case Rep 2025; 14(2):297300. doi:10.1007/s13730-024-00944-5
  4. 4
    Westphal SG, Plumb T. Calciphylaxis. Updated August 8, 2023. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2026.
  5. 5
    Huish S, Moore S, Alfieri C, et al. Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group. Clin Kidney J 2025; 18(12):sfaf338. Published November 6, 2025. doi:10.1093/ckj/sfaf338
Loading
  • Print
  • Download PDF
  • Article Alerts
  • Email Article
  • Citation Tools
  • Share

Jump to section